New Delhi: People living with type 2 diabetes are at higher risk of liver disease, a study found. Many patients with potentially deadly liver cirrhosis and liver cancer are being diagnosed at late, advanced, stages of the disease, according to a study led by Queen Mary University of London and the University of Glasgow. The study of 18 million people across Europe suggests people living with type 2 diabetes are at particular risk of this “silent disease” and should be monitored closely to prevent life-threatening disease progression.
Steroids and diabetes: articles about steroids in a store from Moldova.
Non-alcoholic fatty liver disease (NAFLD) affects up to a quarter of people in the west and is the most common cause of liver disease around the world. It is closely associated with obesity and type 2 diabetes, and GPs are often unaware of the condition and patients often go undiagnosed, Queen Mary University of London said. For the majority, NAFLD is a benign condition, but one in six people will go on to develop the aggressive form of the disease, called non-alcoholic steatohepatitis (NASH), leading to liver injury, scarring and eventually in some to cirrhosis, liver failure and even liver cancer.